The presented package image matches the product design registered with the Ukrainian regulatory authorities.
If you have noticed any differences, please call us at +380 44 490 75 22
DOSAGE FORM
10 tablets in blister, 3 or 9 blisters in a pack; 15 tablets in blister, 6 blisters in a pack.
ACTIVE INGREDIENT
1 tablet contains 200 mg of morpholine salt of tiazotic acid on 100% substance basis, equivalent to 133 mg of the tiazotic acid.
INDICATIONS
In complex treatment of ischemic heart disease: angina pectoris, myocardial infarct, postinfarction cardiosclerosis; cardiac arrhythmia. In complex treatment of chronic hepatitis of different ethiology, including alcoholic hepatitis; hepatic cirrhosis.
If you have information about any adverse effects or other drug-related problems, please fill in the form